Different Residues Mediate Recognition of 1-O-Oleyllysophosphatidic Acid and Rosiglitazone in the Ligand Binding Domain of Peroxisome Proliferator-activated Receptor γ-Reference-Cited by-同舟云学术

Different Residues Mediate Recognition of 1-O-Oleyllysophosphatidic Acid and Rosiglitazone in the Ligand Binding Domain of Peroxisome Proliferator-activated Receptor γ

Published:2006-02 Issue:6 Volume:281 Page:3398-3407
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Tsukahara Tamotsu,Tsukahara Ryoko,Yasuda Satoshi,Makarova Natalia,Valentine William J.,Allison Patrick,Yuan Hongbin,Baker Daniel L.,Li Zaiguo,Bittman Robert,Parrill Abby,Tigyi Gabor

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference70 articles.

1. The role of PPARs in atherosclerosis

2. Discovery of a Novel Series of Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes and Dyslipidemia

3. Peroxisome proliferator–activated receptor-γ agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty

4. The nuclear receptor superfamily: The second decade

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endogenous ether lipids differentially promote tumor aggressiveness by regulating the SK3 channel;Journal of Lipid Research;2024-05

2. Ether-lipids and cellular signaling: A differential role of alkyl- and alkenyl-ether-lipids?;Biochimie;2023-12

3. Molecular basis of unique specificity and regulation of group VIA calcium-independent phospholipase A2 (PNPLA9) and its role in neurodegenerative diseases;Pharmacology & Therapeutics;2023-05

4. Emerging roles of lysophosphatidic acid receptor subtype 5 (LPAR5) in inflammatory diseases and cancer;Pharmacology & Therapeutics;2023-05

5. Peroxisomal regulation of energy homeostasis: Effect on obesity and related metabolic disorders;Molecular Metabolism;2022-11